Antibody responses to borrelia IR6 peptide variants and the C6 peptide in Swedish patients with erythema migrans

International Journal of Medical Microbiology

Volumn 299, Issue 6, 2009, Pages 439-446

  Tjernberg, Ivar ^a,b   Sillanpää, Heidi ^c   Seppälä, Ilkka ^c,d   Eliasson, Ingvar ^e   Forsberg, Pia ^b   Lahdenne, Pekka ^f  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

C6; ELISA; Erythema migrans; IR6 peptide; Lyme borreliosis; Serology

Indexed keywords

ANTIBIOTIC AGENT; C6 PEPTIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENICILLIN V; PROTEIN; SIXTH INVARIANT REGION PEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CHILD; CONTROLLED STUDY; CONVALESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN VARIANT; SCHOOL CHILD; SERODIAGNOSIS; SEROLOGY; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS; MALE; MIDDLE AGED; PEPTIDES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SWEDEN; YOUNG ADULT;

EID: 68749118395     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2008.10.006     Document Type: Article

References (18)

1. ® Quick ELISA™ C6 Borrelia assay kit. Cat no. DK-E392-096, CF-E392-800. Immunetics Inc., Cambridge, MA, USA.
2. ® Borrelia EcoLine IgG/IgM™ Line Immunoblot. Genzyme Virotech, Rüsselsheim, Germany.
3. Bennet L., Fraenkel C.J., Garpmo U., Halling A., Ingman M., Ornstein K., Stjernberg L., and Berglund J. Clinical appearance of erythema migrans caused by Borrelia afzelii and Borrelia garinii - effect of the patient's sex. Wien. Klin. Wochenschr. 118 (2006) 531-537
4. Berglund J., Eitrem R., Ornstein K., Lindberg A., Ringér A., Elmrud H., Carlsson M., Runehagen A., Svanborg C., and Norrby R. An epidemiologic study of Lyme disease in southern Sweden. N. Engl. J. Med. 333 (1995) 1319-1327
5. Cinco M., and Murgia R. Evaluation of the C6 enzyme-linked immunoadsorbent assay for the serodiagnosis of Lyme borreliosis in north-eastern Italy. New Microbiol. 29 (2006) 139-141
6. Feder Jr. H.M., and Whitaker D.L. Misdiagnosis of erythema migrans. Am. J. Med. 99 (1995) 412-419
7. Göttner G., Schulte-Spechtel U., and Wilske B. Heterogeneity of the immunodominant surface protein VlsE among the three genospecies of Borrelia burgdorferi pathogenic for humans. Int. J. Med. Microbiol. 293 Suppl. 37 (2004) 172-173
8. Heikkilä T., Huppertz H.I., Seppälä I., Sillanpää H., Saxen H., and Lahdenne P. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J. Infect. Dis. 187 (2003) 1888-1894
9. Jarefors S., Bennet L., You E., Forsberg P., Ekerfelt C., Berglund J., and Ernerudh J. Lyme borreliosis reinfection: might it be explained by a gender difference in immune response?. Immunology 118 (2006) 224-232
10. Liang F.T., Steere A.C., Marques A.R., Johnson B.J., Miller J.N., and Philipp M.T. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37 (1999) 3990-3996
11. Liang F.T., Aberer E., Cinco M., Gern L., Hu C.M., Lobet Y.N., Ruscio M., Voet Jr. P.E., Weynants V.E., and Philipp M.T. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis. 182 (2000) 1455-1462
12. Nadelman R.B., and Wormser G.P. Reinfection in patients with Lyme disease. Clin. Infect. Dis. 45 (2007) 1032-1038
13. Nyman D., Willén L., Jansson C., Carlsson S.A., Granlund H., and Wahlberg P. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area. Clin. Microbiol. Infect. 12 (2006) 496-497
14. Oksi J., Marttila H., Soini H., Aho H., Uksila J., and Viljanen M.K. Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 109 (2001) 581-588
15. Sillanpää H., Lahdenne P., Sarvas H., Arnez M., Steere A., Peltomaa M., and Seppälä I. Immune responses to borrelial VlsE IR6 peptide variants. Int. J. Med. Microbiol. 297 (2007) 45-52
16. Smismans A., Goossens V.J., Nulens E., and Bruggeman C.A. Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. Clin. Microbiol. Infect. 12 (2006) 648-655
17. Tjernberg I., Krüger G., and Eliasson I. C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden. Eur. J. Clin. Microbiol. Infect. Dis. 26 (2007) 37-42
18. Wilske B. Epidemiology and diagnosis of Lyme borreliosis. Ann. Med. 37 (2005) 568-579